These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 10668587

  • 21. [Multicenter evaluation of the antimicrobial activity in vitro for six broad-spectrum beta-lactams in China using the E-test method].
    Xu Y, Chen M, Zhang S.
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):362-5. PubMed ID: 11798789
    [Abstract] [Full Text] [Related]

  • 22. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [Abstract] [Full Text] [Related]

  • 23. Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: comparison of data from 1997 and 1998 using the Etest method. Venezuelan Antimicrobial Resistance Study Group.
    Pfaller MA, Jones RN, Doern GV.
    Diagn Microbiol Infect Dis; 1999 Oct; 35(2):153-8. PubMed ID: 10579096
    [Abstract] [Full Text] [Related]

  • 24. Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014.
    Sader HS, Castanheira M, Mendes RE, Flamm RK, Jones RN.
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137811
    [Abstract] [Full Text] [Related]

  • 25. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ, Wang H, China Nosocomial Pathogens Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):375-81. PubMed ID: 12820912
    [Abstract] [Full Text] [Related]

  • 26. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Pfaller MA, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Sep 10; 56(1):63-8. PubMed ID: 16650951
    [Abstract] [Full Text] [Related]

  • 27. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
    Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB, Wenzel RP.
    Diagn Microbiol Infect Dis; 1997 Aug 10; 28(4):211-9. PubMed ID: 9327251
    [Abstract] [Full Text] [Related]

  • 28. In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus.
    Tallis E, Rudensky B, Attias D, Raveh D, Schlesinger Y, Yinnon AM.
    Diagn Microbiol Infect Dis; 1999 Oct 10; 35(2):121-6. PubMed ID: 10579092
    [Abstract] [Full Text] [Related]

  • 29. In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
    Bauernfeind A, Schweighart S, Eberlein E, Jungwirth R.
    Infection; 1991 Oct 10; 19 Suppl 5():S264-75. PubMed ID: 1664418
    [Abstract] [Full Text] [Related]

  • 30. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
    Tuchiluş C, Poiată A, Bădicuţ I, Teodor A, Luca V, Grigore L, Buiuc D.
    Rev Med Chir Soc Med Nat Iasi; 2003 Oct 10; 107(3):595-8. PubMed ID: 14756068
    [Abstract] [Full Text] [Related]

  • 31. [In vitro antimicrobial activity of cefpirome compared to other broad-spectrum beta-lactam drugs against 804 clinical isolates from 9 Brazilian hospitals].
    Sader HS, Mendes CM, Montelli A, Sampaio J, Segura AJ, Kesselring GL, Costa L, Ribeiro JE, Mamizuka E, Mimiça I.
    Rev Assoc Med Bras (1992); 1998 Oct 10; 44(4):283-8. PubMed ID: 9852647
    [Abstract] [Full Text] [Related]

  • 32. In vitro activity of cefepime and other broad-spectrum beta-lactams tested against 129 mec A-negative Staphylococcus spp. isolates: a multicenter sample.
    Marshall SA, Wilke WW, Chen YS, Pfaller MA, Jones RN.
    Diagn Microbiol Infect Dis; 1998 Jan 10; 30(1):65-9. PubMed ID: 9488834
    [Abstract] [Full Text] [Related]

  • 33. Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime.
    Frei R, Jones RN, Pignatari AC, Yamane N, Marco F, Hoban DJ.
    Diagn Microbiol Infect Dis; 1994 Mar 10; 18(3):167-73. PubMed ID: 7924209
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
    Jones RN, Marshall SA.
    Diagn Microbiol Infect Dis; 1994 May 10; 19(1):33-8. PubMed ID: 7956010
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group.
    Doern GV, Jones RN, Pfaller MA, Erwin M, Ramirez-Rhonda C.
    Diagn Microbiol Infect Dis; 1998 Feb 10; 30(2):113-9. PubMed ID: 9554179
    [Abstract] [Full Text] [Related]

  • 40. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
    Fritsche TR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2008 May 10; 61(1):86-95. PubMed ID: 18385000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.